Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
0.618
+0.051 (8.91%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ovid Therapeutics Employees
Ovid Therapeutics had 40 employees as of December 31, 2023. The number of employees decreased by 4 or -9.09% compared to the previous year.
Employees
40
Change (1Y)
-4
Growth (1Y)
-9.09%
Revenue / Employee
$15,792
Profits / Employee
-$812,549
Market Cap
43.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
OVID News
- 17 days ago - Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 5 months ago - Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth - GlobeNewsWire
- 6 months ago - Shareholders In Ovid Therapeutics Inc Invited To Participate In Fraud Investigation With The Schall Law Firm - Accesswire
- 6 months ago - Ovid Therapeutics Inc Investors Encouraged To Join Fraud Investigation With Schall Law Firm - Accesswire
- 6 months ago - Ovid Therapeutics Inc Shareholders Eligible To Participate In Fraud Investigation With Schall Law Firm - Accesswire
- 6 months ago - Ovid Therapeutics Inc Investors Invited To Join In Fraud Investigation With Schall Law Firm - Accesswire
- 6 months ago - Ovid Therapeutics Inc Shareholders Encouraged To Join Fraud Investigation With Schall Law Firm - Accesswire
- 6 months ago - Ovid Therapeutics Inc Shareholders Invited To Join Fraud Investigation With Schall Law Firm - Accesswire